Market Snapshot: Vascular Access Site Closure Market Expected To Rise 6.5% By 2022
Executive Summary
The global market for vascular access site closure products is expected to reach $1bn in 2022, driven in large part by the rising prevalence of cardiovascular disease, the leading cause of death globally. The most dominant trend in this market is the development of vascular closure devices for larger arteriotomies. Large-bore procedures, such as transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair, will drive demand for vascular closure devices. Due to complications associated with active vascular closure devices, the use of passive vascular closure devices is on the rise. Check out our infographic for details.
You may also be interested in...
Menopause Research To Benefit From White House Initiative To Bolster Women’s Health
Women’s health leaders in the menopause space have high hopes that President Biden’s executive order will provide dollars for more research on how hormone therapy can prevent disease and draw attention to the need for provider education on menopausal symptoms.
BD’s CTO Beth McCombs Discusses Key Initiatives – AI/Gen AI; DE&I Strategy; Succession Planning
BD CTO Beth McCombs discusses her role in driving innovation, including the integration of AI and generative AI to create efficiencies, and passion for creating a culture of inclusion, diversity and equity.
Digital Health Roundup: Impact Of EU’s AI Act On Device Makers; Verily's Andrew Trister’s Vision For Personal AI Agent
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights her interview with Verily’s CMO and CSO, Andrew Trister at ViVE on leveraging AI for precision health and a DHIS West conference panel discussion on use cases of generative AI. Elizabeth Orr discusses the impact on the newly adopted EU AI Act on device makers and concerns raised by industry members.